| known also as: |
C-term, Anti-PRAM1 antibody [C3] |
| known also as: |
Anti- [C3], C-term, PRAM1 |
| known also as: |
C-term, PRAM1 antibody [C3] |
| known also as: |
PRAM1 [C3] |
| known also as: |
MGC39864, PML-RAR, PML-RARA regulated adaptor molecule 1, PML-RARA regulated adaptor molecule 1, PML-RARA target gene encoding an Adaptor Molecule-1, PML-RARA-regulated adapter molecule 1, PRAM, PRAM-1, PRAM1, Rabbit Polyclonal antibody to PRAM1 (PML-RARA regulated adaptor molecule 1) |
| Other names: |
N/A, PML-RARA regulated adaptor molecule 1, PML-RARA target gene encoding an Adaptor Molecule-1, PML-RARA-regulated adapter molecule 1, PML-RARA-regulated adapter molecule 1, PRAM, PML-RARA-regulated adapter molecule 1 |
| Gene name: |
PRAM1 |
| Other gene names: |
PML-RAR, PRAM, PRAM-1, PRAM-1, PRAM1, PRAM1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Rabbit |
| Species reactivity: |
Human |
| Purification method: |
Purified by antigen-affinity chromatography |
| Form/Appearance: |
Liquid |
| Concentration: |
5 mg/ml |
| Storage and shipping: |
Aliquot and store at -20 degrees Celsius, Multiple freeze-thaw cycles should be avoided as they may damage the peptide chains and/or other components and reduce the activity, The product should be kept as concentrated solution |
| Tested for:: |
Western Blot (WB), Immunohistochemistry (IHC) Paraffin |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| French translation: |
anticorps |
| Gene target: |
PRAM1 [C3] C-term |
| Short name: |
PRAM1 antibody [C3] C-term |
| Alternative name: |
alpha regulated adaptor molecule 1 (Antibody to) [complement component 3], c terminus, promyelocytic leukemia-retinoic acid receptor |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
AHUS5 and ARMD9 and ASP and C3a and C3b and CPAMD1 and HEL-S-62p, BT, C3 and IDBG-193788 and ENSMUSG00000024164 and 102642251, C3 and IDBG-21798 and ENSG00000125730 and 718, C5L2 anaphylatoxin chemotactic receptor binding, Extracellular, PML-RARA regulated adaptor molecule 1, PRAM1 and IDBG-24943 and ENSG00000133246 and 84106, PRAM1 and IDBG-643837 and ENSBTAG00000021041 and 504848, Pram1 and IDBG-167526 and ENSMUSG00000032739 and 378460, alternative pathway and biological process this GO :0006958 and complement activation, classical pathway and biological process this GO :0007165 and signal transduction and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0010575 and positive regulation vascular endothelial growth factor production and biological process this GO :0010828 and positive regulation of glucose transport and biological process this GO :0010866 and regulation of triglyceride biosynthetic process and biological process this GO :0010884 and positive regulation of lipid storage and biological process this GO :0010951 and negative regulation of endopeptidase activity and biological process this GO :0030449 and regulation of complement activation and biological process this GO :0031715 and C5L2 anaphylatoxin chemotactic receptor binding and molecular function this GO :0045087 and innate immune response and biological process this GO :0045745 and positive regulation of G-protein coupled receptor protein signaling pathway and biological process this GO :0045766 and positive regulation of angiogenesis and biological process this GO :0050766 and positive regulation of pha this GO cytosis and biological process this GO :0050776 and regulation of immune response and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0072562 and blood microparticle and cellular component this GO :2000427 and positive regulation of apoptotic cell clearance and biological process, lipid binding, multiple, this GO :0001798 and positive regulation of type IIa hypersensitivity and biological process this GO :0001934 and positive regulation of protein phosphorylation and biological process this GO :0001970 and positive regulation of activation of membrane attack complex and biological process this GO :0004866 and endopeptidase inhibitor activity and molecular function this GO :0005102 and receptor binding and molecular function this GO :0005515 and protein binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005886 and plasma membrane and cellular component this GO :0006631 and fatty acid metabolic process and biological process this GO :0006954 and inflammatory response and biological process this GO :0006955 and immune response and biological process this GO :0006956 and complement activation and biological process this GO :0006957 and complement activation, this GO :0004866 : endopeptidase inhibitor activity, this GO :0004866 : endopeptidase inhibitor activity and also this GO :0005102 : receptor binding and also this GO :0005515 : protein binding and also this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, this GO :0005102 : receptor binding, this GO :0005515 and protein binding and molecular function this GO :0007229 and integrin-mediated signaling pathway and biological process this GO :0008289 and lipid binding and molecular function this GO :0043313 and regulation of neutrophil degranulation and biological process, this GO :0005515 : protein binding, this GO :0005515 : protein binding, this GO :0005515 : protein binding and also this GO :0008289 : lipid binding, this GO :0008289 : lipid binding, this GO :0031715 : C5L2 anaphylatoxin chemotactic receptor binding, 12266, 19562 and IDBG-643930 and ENSBTAG00000017280 and 280677, complement component 3 |
| Identity: |
30091 |
| Gene: |
PRAM1 |
More about : PRAM1 |
| Long gene name: |
PML-RARA regulated adaptor molecule 1 |
| Synonyms: |
PML-RAR |
| Locus: |
19p13, 2 |
| Discovery year: |
2005-07-04 |
| GenBank acession: |
BC028012 |
| Entrez gene record: |
84106 |
| Pubmed identfication: |
11301322 15572693 |
| RefSeq identity: |
NM_032152 |
| Havana BLAST/BLAT: |
OTTHUMG00000167924 |